Aldeyra Therapeutics (ALDX) Prices 10M Share IPO at $12.50/Sh
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/22/2026
- S&P 500, Nasdaq close lower, dragged by Alphabet and megacap tech; focus on Iran
- Oil settles down more 3% after US-Iran talks signal easing supply risks
- Micron surges 5.5% on blockbuster Anthropic AI deal ahead of earnings
- Alan Greenspan, influential former Federal Reserve chair, dies at 100
- Buy gold stocks as valuations are cheap amid macro tension: BofA
- CoreWeave trains DeepSeek-V3 in two minutes in MLPerf benchmark
- Needham Starts NeoVolta (NEOV) at Buy
- Spain's ex-transport minister sentenced to 24 years for corruption
- Li Auto Inc. (LI) Breaks Ground on Chips R&D and Production Base
- Exclusive-China robot-hand-building unicorn Linkerbot targets $6 billion valuation
Aldeyra Therapeutics (ALDX) Announces Proposed $125 Million Public Offering of Common Stock
April 27, 2021 4:08 PM EDTAldeyra Therapeutics, Inc. (Nasdaq: ALDX) (Aldeyra), a clinical-stage biotechnology company focused on the development of novel therapies with the potential to improve the lives of patients with immune-mediated diseases, today announced that it intends to offer and sell, subject to market and other... More
Aldeyra Therapeutics (ALDX) PT Raised to $16 at Oppenheimer, Following Clinical Update
April 27, 2021 3:29 PM EDTOppenheimer analyst Yichuan (Jackie) Yan raised the price target on Aldeyra Therapeutics (NASDAQ: ALDX) to $16.00 (from $15.00) while maintaining a Outperform rating.
... MorePre-Open Movers 04/27: (FCBP) (GMBL) (ALDX) Higher; (RNWK) (AGTC) (HYFM) Lower (more...)
April 27, 2021 9:27 AM EDTPre-Open Stock Movers:
First Choice Bancorp (Nasdaq: FCBP) 24.3% HIGHER; Enterprise Financial Services Corp (Nasdaq: EFSC) and First Choice Bancorp (Nasdaq: FCBP) announced today that EFSC, EB&T, FCBP and First Choice have entered into a definitive merger agreement pursuant to which EFSC will acquire, in an all-stock merger, FCBP.
RealNetworks, Inc. (NASDAQ: RNWK) 19% LOWER; commenced a proposed underwritten public offering of its common stock pursuant to RealNetworks' shelf registration... More
Aldeyra Therapeutics (ALDX) to Resume Trading at 7:30 a.m.
April 27, 2021 7:16 AM EDTAldeyra Therapeutics (NASDAQ: ALDX) to Resume Trading at 7:30 a.m.
Aldeyra Therapeutics (ALDX) Achieves Statistical Significance for Primary Endpoint and All Secondary Endpoints in Phase 3 INVIGORATE Clinical Trial of Reproxalap in Allergic Conjunctivitis
April 27, 2021 7:03 AM EDTAldeyra Therapeutics, Inc. (Nasdaq: ALDX) (Aldeyra), a clinical-stage biotechnology company focused on the development of novel therapies with the potential to improve the... More
Aldeyra Therapeutics (ALDX) Halted for News
April 27, 2021 7:02 AM EDTAldeyra Therapeutics (NASDAQ: ALDX) Halted for News
... More